tradingkey.logo

Sanofi To Acquire Dren Bio’s Bispecific Myeloid Cell Engager For Deep B-Cell Depletion

ReutersMar 20, 2025 6:07 AM

- Sanofi SA SASY.PA:

  • PRESS RELEASE: SANOFI TO ACQUIRE DREN BIO’S BISPECIFIC MYELOID CELL ENGAGER FOR DEEP B-CELL DEPLETION, BROADENING IMMUNOLOGY PIPELINE

  • TO PAY $600 MILLION UP FRONT

  • DEAL INCLUDES POTENTIAL FUTURE PAYMENTS TOTALING $1.3 BILLION

  • TRANSACTION EXPECTED TO CLOSE DURING Q2 2025

  • TO FINANCE TRANSACTION WITH AVAILABLE CASH RESOURCES

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI